Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Narrative (Details)

v3.25.0.1
Income Taxes - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]      
Change in valuation allowance $ 315,000 $ 2,831,000  
Capitalized research and development costs 14,785,000 11,530,000 $ 3,255,000
Operating loss carryforwards 37,323,000    
Income tax expense (benefit) $ 0 $ 0 $ 0